CELLTIUM is pioneering a biotechnological revolution to enhance human health and well-being, focusing on conquering debilitating neurological disorders.

​

Charcot-Marie-Tooth disease and related neuropathies, though rare, severely impact millions worldwide. The global rise in diabetes and chemotherapy-induced nerve damage urgently demands innovative solutions.

​

Driven by unwavering dedication, CELLTIUM’s expert scientists are relentlessly pursuing breakthroughs. Leveraging our cutting-edge platform and deep scientific expertise, we create hope and innovation, developing innovative therapies that overcome the limitations of current treatments. Our precise strategies are poised to transform the market, delivering First-in-Class curative treatments for long-standing unmet medical needs.

​

CELLTIUM is deeply honored to transform patient lives. We sincerely appreciate your partnership on this journey of scientific discovery.

​

CELLTIUM INC